Healthcare -
Biotechnology - NASDAQ - US
$ 5.06
6.75 %
$ 287 M
Market Cap
-5.95
P/E
DSGN - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss DSGN - Design Therapeutics, Inc.
62 K
LAST VALUE
50.14%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR